U.S. Senator charges “scientific” support of drugs often written by Pharma ghost writers
The full scope of the ghostwriting problem is still unclear, but recent revelations suggest that the practice is widespread. Dozens of medical education companies across the country draft scientific papers at the behest of drug makers. And placing such papers in medical journals has become a fundamental marketing practice for most of the large pharmaceutical companies.
SHARE YOUR STORY/COMMENT: